Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

Please share Science & Enterprise

New Venture Funds to Back Life Science, Tech Start-Ups

Investor screen

Three new venture funds are seeking to invest up to $6.3 billion in start-up companies with advances in life sciences, health care, energy, and information technologies. . . . → Read More: New Venture Funds to Back Life Science, Tech Start-Ups

Grocery Chain Offering Sites for Cancer Biomarker Trial

Kroger store in Kentucky

The Kroger grocery store chain in the U.S. is establishing a clinical trial network through its urgent care centers, starting with a study of microbiome cancer biomarkers. . . . → Read More: Grocery Chain Offering Sites for Cancer Biomarker Trial

Damaged Human Lungs Restored for Transplantation

Yorkshire swine in a barn

A research team demonstrated the feasibility of connecting anesthetized pigs to human lungs deemed unfit for transplants, for recovering the lungs to transplant quality. . . . → Read More: Damaged Human Lungs Restored for Transplantation

Psychedelic Drug Shown to Relieve PTSD Brain Signals

Brain circuits

A small clinical trial shows psychotherapy with the psychedelic drug MDMA generates brain signals that help relieve symptoms in people with post-traumatic stress disorder. . . . → Read More: Psychedelic Drug Shown to Relieve PTSD Brain Signals

Biotech, Academic Lab Partner on Microbiome-Safe Products

Spray bottle

A biotechnology company creating products for gut health and a university immunology lab are evaluating cleaning products for potential damage to human protective tissues. . . . → Read More: Biotech, Academic Lab Partner on Microbiome-Safe Products

Nasal Spray Vaccine Shown to Stop Gonorrhea Infections

Neisseria gonorrhoeae bacteria

A vaccine against gonorrhea given as a nasal spray is shown to generate protective immune responses in lab mice of both sexes, and in females similar to an intravaginal vaccine. . . . → Read More: Nasal Spray Vaccine Shown to Stop Gonorrhea Infections

CEPI Assessing Advanced RNA Nanoparticle Vaccine

Zika virus

An international health organization is evaluating a new type of vaccine made with biodegradable RNA nanoparticles to help head off future viral pandemics. . . . → Read More: CEPI Assessing Advanced RNA Nanoparticle Vaccine

Project to Sequence 20K Dog and Cat Genomes

Dog's nose

Some 20,000 dogs and cats are expected to have their genomes sequenced in the next 10 years for a publicly available database to enable precision medicine for pets. . . . → Read More: Project to Sequence 20K Dog and Cat Genomes

BioNTech to Provide Personal Cancer Immunotherapies in UK

Vials and bottles

The biotechnology company BioNTech SE is partnering with the U.K. government to provide up to 10,000 personalized cancer immunotherapy treatments by 2030. . . . → Read More: BioNTech to Provide Personal Cancer Immunotherapies in UK

Biotech Alliance Creating Circular RNA Cancer Drug

Cancer on clipboard

A partnership of biotechnology components and therapy companies aims to develop new drugs made from circular forms of RNA, starting with a colorectal cancer treatment. . . . → Read More: Biotech Alliance Creating Circular RNA Cancer Drug